Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alphamab Oncology, Ascentage, Beigene, Biontech, Carsgen, Glaxosmithkline, Janssen-Cilag, Johnson & Johnson, Kintor, Merck, Moderna, Novavax, Pfizer, RDIF, Relief, Seqirus, Takeda.